Publications by authors named "M Cani"

Claim this Profile
I
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50.
A De Giglio, L Zullo, A Di Federico, M Cani, M Aldea

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supraclavicular Lymph Node Metastases in Advanced Lung Cancer: Prevalence and Analysis of Demographic, Clinical and Molecular Characteristics.
Rocco Trisolini, Valeria Cetoretta, Giovanni Sotgiu, Alessandra Cancellieri, Mariangela Puci, Massimiliano Cani

Clin Lung Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors of long-term response to androgen receptor signaling inhibitors used as first-line treatment for mCRPC.
Antonello Veccia, Umberto Basso, Carlo Cattrini, Paola Ermacora, Marco Maruzzo, Massimiliano Cani

Future Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA dynamic variation predicts sotorasib efficacy in KRASp.G12C-mutated advanced non-small cell lung cancer.
Francesco Passiglia, Francesco Pepe, Gianluca Russo, Edoardo Garbo, Angela Listì, Massimiliano Cani

Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving landscape of stage III unresectable non-small cell lung cancer "between lights and shadows".
Marco Donatello Delcuratolo, Veronica Crespi, Giorgio Saba, Andrea Mogavero, Valerio Maria Napoli, Massimiliano Cani

Cancer Treat Rev· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis